Ferring Pharmaceuticals Expands in Parsippany with FDA-Approved Manufacturing Hub
Ferring Pharmaceuticals received FDA approval for its new Drug Product Manufacturing Hub in Parsippany, enhancing its production capabilities for ADSTILADRIN. The 12,000-square-foot facility is part of a larger U.S. Operations Center and reflects Ferring's commitment to sustainability and local community support.